Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Simply Solventless Concentrates EV-to-EBIT?
Simply Solventless ConcentratesSSLCF EV-to-EBIT is 1.84 as of Jul. 18, 2026, which is 39% below its 10-year median of 3.03. The stock has 4 warning signs investors should review. Among 689 Drug Manufacturers companies, Simply Solventless Concentrates ranks better than 95.36% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Simply Solventless Concentrates's Enterprise Value for the quarter that ended in Sep. 2025 was $33.52 Mil.
Simply Solventless Concentrates's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.19 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Simply Solventless Concentrates EV-to-EBIT Related Terms
Simply Solventless Concentrates EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Simply Solventless Concentrates's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simply Solventless Concentrates EV-to-EBIT vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Simply Solventless Concentrates's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Simply Solventless Concentrates's EV-to-EBIT falls into.
Simply Solventless Concentrates's current Enterprise Value is $15.04 Mil.
Simply Solventless Concentrates's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.19 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Simply Solventless Concentrates (SSLCF) has a EV-to-EBIT of 1.84 as of Jul. 18, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Simply Solventless Concentrates and its competitors. This is 39% below median its historical median of 3.03. According to the industry distribution chart, Simply Solventless Concentrates ranks #32 out of 689 companies in the Drug Manufacturers industry, placing it in the top 4.6%.
Is Simply Solventless Concentrates' EV-to-EBIT too high?
Simply Solventless Concentrates' current EV-to-EBIT of 1.84 is 39% below median its 10-year median of 3.03. The Drug Manufacturers industry median EV-to-EBIT is 15.73. Simply Solventless Concentrates' value of 1.84 is 88.3% below this industry median. Based on the distribution chart, Simply Solventless Concentrates ranks #32 out of 689 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Simply Solventless Concentrates' EV-to-EBIT compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Simply Solventless Concentrates ranks #32 out of 689 companies for EV-to-EBIT. This places Simply Solventless Concentrates in the top 5% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 15.73. Simply Solventless Concentrates' value of 1.84 is 88.3% below this benchmark. While the company's 10-year median is 3.03 vs. the industry median of 15.73, Simply Solventless Concentrates has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 15.73, based on 689 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Simply Solventless Concentrates's current EV-to-EBIT of 1.84 is 88.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Simply Solventless Concentrates and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simply Solventless Concentrates's current EV-to-EBIT is 1.84, which is 39% below median its own 10-year median of 3.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simply Solventless Concentrates stock overvalued right now?
Simply Solventless Concentrates (SSLCF) has a current EV-to-EBIT of 1.84. The current EV-to-EBIT is 1.84, which is 39% below median its 10-year median of 3.03 and 88.3% below the Drug Manufacturers industry median of 15.73. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Simply Solventless Concentrates (SSLCF), the current EV-to-EBIT is 1.84 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Simply Solventless Concentrates Business Description
Simply Solventless Concentrates Ltd is a company that provides pure, potent, terpene-rich solvent less concentrates to discerning cannabis consumers. The company serves the recreational, medical, and business-to-business cannabis markets in Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSLCF has been successfully added to your 
